BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
ROS↑, NRF2↑, Inflam↓, frataxin↑, *BioAv↓, ChemoSen↑, Hif1a↓, eff↑, FAK↓, ITGB1↓, MMP2↓, MMP9↓, EMT↓, Snail↓, Vim↓, Zeb1↓, P53↑, MGMT↓, Mcl-1↓, Bcl-xL↓, Bcl-2↓, survivin↓, Casp3↑, Casp9↑, BAX↑, p‑Akt↓, GSK‐3β↓, *antiOx↑, *ROS↓, selectivity↑, angioG↓, MMPs↓, NF-kB↓, ITGB3↓, NADPH↓,
*BioAv↑, *BioAv↑, *BioAv↑, *BioAv↓, *eff↑,
*antiOx?, *Inflam↓, Apoptosis↑, TumCCA↑, BAX↑, eff↑, VEGF↓, PI3K↓, Akt↓, mTOR↓, Telomerase↓, β-catenin/ZEB1↓, Wnt↓, EGFR↓, AP-1↓, NF-kB↓, COX2↑, NRF2↓, RadioS↑, STAT3↓, ERK↓, AR↓, ROS↑, eff↑, selectivity↑, selectivity↑, BioAv↓, DNMT1↓, cMyc↓,
AntiCan↑, BioAv↓, toxicity⇅, TOP1↓, Apoptosis↑, TumCP↓, other↝, BioAv↑, other↝, eff↑,
*AntiCan↑, *cardioP↑, *neuroP↑, *BioAv↝, *BioAv↓, *BioAv↓, *Dose↝, *Half-Life↝, *BioAv↑, *BBB↑, *hepatoP↓, *other↓, *Inflam↓, *NF-kB↓, *AP-1↓, *iNOS↓, *COX2↓, *ROS↓, *RNS↓, *IL8↓, *JAK↓, *PDGFR-BB↓, *IGF-1R↓, *MMP2↓, *P53↓, *NRF2↑, *TNF-α↓, *IL6↓, *E2Fs↑, *SOD1↑, *SOD2↑, Casp3↑, Cyt‑c↑, PARP↑, DNMTs↓, Telomerase↓, Hif1a↓, MMPs↓, BAX↑, Bak↑, Bcl-2↓, Bcl-xL↓, P53↑, PTEN↑, TumCP↓, MAPK↓, HGF/c-Met↓, TIMP1↑, HDAC↓, MMP9↓, uPA↓, GlutMet↓, ChemoSen↑, chemoP↑,
| - |
in-vitro, |
MB, |
DAOY |
|
|
|
- |
vitro+vivo, |
NA, |
NA |
|
|
|
BioAv↓, BioAv↓, TumCP↓, selectivity↑, P53↑, P21↑, CDK4↓, cycD1/CCND1↓, mtDam↑, ROS↑, eff↓, Casp3↑, BAX↑, LC3II↑, Beclin-1↑, ATG7↑, p62↑, eff↑, ChemoSen↑, *toxicity↓,
*antiOx↑, *Inflam↓, AntiTum↑, *BioAv↓, *Half-Life↓, *BioAv↝, *BioAv↓,
| - |
in-vitro, |
BC, |
4T1 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
BioAv↓, BioAv↑, eff↑, tumCV↓, e-H2O2↓, i-H2O2∅,
*BioAv↝, *BioAv↓, *ROS⇅, *BioAv↝,
*Ca+2↑, *Dose↝, *BioAv↓,
Inflam↓, antiOx↓, AntiCan↑, BioAv↓, BioAv↓, BioAv↑, INF-γ↓, IL6↓, TNF-α↓, IL10↑, CRP↓,
Half-Life↝, BioAv↓, Half-Life↝, BioAv↓,
*BioAv↓, *Half-Life↓,
| - |
in-vitro, |
Pca, |
HEK293 |
|
|
|
- |
in-vitro, |
NA, |
22Rv1 |
|
|
|
- |
in-vitro, |
NA, |
C4-2B |
|
|
|
hnRNPA1↓, PSA↓, NKX3.1↓, FKBP5↓, UBE2C↓, AR-FL↓, AR-V7↑, AR↓, eff↑, TumVol↓, BioAv↓,
*BioAv↓,
| - |
Review, |
NA, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
NF-kB↓, P450↓, COX2↓, Hif1a↓, VEGF↓, *SIRT1↑, SIRT1↓, SIRT2↓, ChemoSen⇅, cardioP↑, *memory↑, *angioG↑, *neuroP↑, STAT3↓, CSCs↓, RadioS↑, Nestin↓, Nanog↓, TP53↑, P21↑, CXCR4↓, *BioAv↓, EMT↓, Vim↓, Slug↓, E-cadherin↑, AMPK↑, MDR1↓, DNAdam↑, TOP2↓, PTEN↑, Akt↓, Wnt↓, β-catenin/ZEB1↓, cMyc↓, MMP7↓, MALAT1↓, TCF↓, ALDH↓, CD44↓, Shh↓, IL6↓, VEGF↓, eff↑, HK2↓, ROS↑, MMP↓,
*ROS↓, *IronCh↑, *MMP↑, *NRF2↑, *Inflam↓, *hepatoP↑, *HSPs↑, *Trx↑, *SIRT2↑, *GSH↑, *ROS↑, *NADPH↓, *iNOS↓, *NF-kB↓, *BioAv↓, *Dose↝, *BioAv↑,
hepatoP↑, AntiCan↑, TumCMig↓, Hif1a↓, selectivity↑, toxicity∅, *antiOx↑, *Inflam↓, TumCCA↑, P21↑, CDK4↓, NF-kB↓, ERK↓, PSA↓, TumCG↓, p27↑, COX2↓, IL1↓, VEGF↓, IGFBP3↑, AR↓, STAT3↓, Telomerase↓, Cyt‑c↑, Casp↑, eff↝, HDAC↓, HATs↑, Zeb1↓, E-cadherin↑, miR-203↑, NHE1↓, MMP2↓, MMP9↓, PGE2↓, Vim↓, Wnt↓, angioG↓, VEGF↓, *TIMP1↓, EMT↓, TGF-β↓, CD44↓, EGFR↓, PDGF↓, *IL8↓, SREBP1↓, MMP↓, ATP↓, uPA↓, PD-L1↓, NOTCH↓, *SIRT1↑, SIRT1↓, CA↓, Ca+2↑, chemoP↑, cardioP↑, Dose↝, Half-Life↝, BioAv↓, BioAv↓, BioAv↓, toxicity↝, Half-Life↓, ROS↓, FAK↓,
| - |
in-vitro, |
Ovarian, |
A2780S |
|
|
|
- |
in-vivo, |
NA, |
A2780S |
|
|
|
*BioAv↓, ROS↑, GSH↓, TumCG↓,
BioAv↓, P-gp↑, MRP1↑, ROS↑, *BioAv↓,
ChemoSideEff↓, ROS↑, H2O2↑, Fenton↑, Hif1a↝, Dose↑, BioAv↓, Dose↝, Half-Life↝, IL1β↓, IL2↓, IL8↓, TNF-α↓,
Showing Research Papers: 1 to 21 of 21
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 21
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↓, 1, Fenton↑, 1, frataxin↑, 1, GSH↓, 1, H2O2↑, 1, e-H2O2↓, 1, i-H2O2∅, 1, NRF2↓, 1, NRF2↑, 1, ROS↓, 1, ROS↑, 7,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MMP↓, 2, mtDam↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, ATG7↑, 1, cMyc↓, 2, GlutMet↓, 1, HK2↓, 1, NADPH↓, 1, SIRT1↓, 2, SIRT2↓, 1, SREBP1↓, 1,
Cell Death ⓘ
Akt↓, 2, p‑Akt↓, 1, Apoptosis↑, 2, Bak↑, 1, BAX↑, 4, Bcl-2↓, 2, Bcl-xL↓, 2, Casp↑, 1, Casp3↑, 3, Casp9↑, 1, Cyt‑c↑, 2, HGF/c-Met↓, 1, MAPK↓, 1, Mcl-1↓, 1, p27↑, 1, survivin↓, 1, Telomerase↓, 3,
Transcription & Epigenetics ⓘ
HATs↑, 1, other↝, 2, tumCV↓, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, LC3II↑, 1, p62↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, DNMT1↓, 1, DNMTs↓, 1, MGMT↓, 1, NKX3.1↓, 1, P53↑, 3, PARP↑, 1, TP53↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 2, cycD1/CCND1↓, 1, P21↑, 3, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
ALDH↓, 1, AR-FL↓, 1, AR-V7↑, 1, CD44↓, 2, CSCs↓, 1, EMT↓, 3, ERK↓, 2, GSK‐3β↓, 1, HDAC↓, 2, IGFBP3↑, 1, mTOR↓, 1, Nanog↓, 1, Nestin↓, 1, NOTCH↓, 1, PI3K↓, 1, PTEN↑, 2, Shh↓, 1, STAT3↓, 3, TCF↓, 1, TOP1↓, 1, TOP2↓, 1, TumCG↓, 2, Wnt↓, 3,
Migration ⓘ
AP-1↓, 1, CA↓, 1, Ca+2↑, 1, E-cadherin↑, 2, FAK↓, 2, hnRNPA1↓, 1, ITGB1↓, 1, ITGB3↓, 1, MALAT1↓, 1, miR-203↑, 1, MMP2↓, 2, MMP7↓, 1, MMP9↓, 3, MMPs↓, 2, PDGF↓, 1, Slug↓, 1, Snail↓, 1, TGF-β↓, 1, TIMP1↑, 1, TumCMig↓, 1, TumCP↓, 3, uPA↓, 2, Vim↓, 3, Zeb1↓, 2, β-catenin/ZEB1↓, 2,
Angiogenesis & Vasculature ⓘ
angioG↓, 2, EGFR↓, 2, Hif1a↓, 4, Hif1a↝, 1, VEGF↓, 5,
Barriers & Transport ⓘ
NHE1↓, 1, P-gp↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 2, COX2↑, 1, CRP↓, 1, CXCR4↓, 1, IL1↓, 1, IL10↑, 1, IL1β↓, 1, IL2↓, 1, IL6↓, 2, IL8↓, 1, INF-γ↓, 1, Inflam↓, 2, NF-kB↓, 4, PD-L1↓, 1, PGE2↓, 1, PSA↓, 2, TNF-α↓, 2,
Hormonal & Nuclear Receptors ⓘ
AR↓, 3, FKBP5↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 15, BioAv↑, 3, ChemoSen↑, 3, ChemoSen⇅, 1, Dose↑, 1, Dose↝, 2, eff↓, 1, eff↑, 8, eff↝, 1, Half-Life↓, 1, Half-Life↝, 4, MDR1↓, 1, MRP1↑, 1, P450↓, 1, RadioS↑, 2, selectivity↑, 5,
Clinical Biomarkers ⓘ
AR↓, 3, CRP↓, 1, EGFR↓, 2, IL6↓, 2, PD-L1↓, 1, PSA↓, 2, TP53↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 3, AntiTum↑, 1, cardioP↑, 2, chemoP↑, 2, ChemoSideEff↓, 1, hepatoP↑, 1, toxicity⇅, 1, toxicity↝, 1, toxicity∅, 1, TumVol↓, 1, UBE2C↓, 1,
Total Targets: 166
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx?, 1, antiOx↑, 3, GSH↑, 1, NRF2↑, 2, RNS↓, 1, ROS↓, 3, ROS↑, 1, ROS⇅, 1, SOD1↑, 1, SOD2↑, 1, Trx↑, 1,
Metal & Cofactor Biology ⓘ
IronCh↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 1,
Core Metabolism/Glycolysis ⓘ
NADPH↓, 1, SIRT1↑, 2, SIRT2↑, 1,
Cell Death ⓘ
iNOS↓, 2,
Transcription & Epigenetics ⓘ
other↓, 1,
Protein Folding & ER Stress ⓘ
HSPs↑, 1,
DNA Damage & Repair ⓘ
P53↓, 1,
Cell Cycle & Senescence ⓘ
E2Fs↑, 1,
Proliferation, Differentiation & Cell State ⓘ
IGF-1R↓, 1,
Migration ⓘ
AP-1↓, 1, Ca+2↑, 1, MMP2↓, 1, TIMP1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↑, 1, PDGFR-BB↓, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IL6↓, 1, IL8↓, 2, Inflam↓, 5, JAK↓, 1, NF-kB↓, 2, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 14, BioAv↑, 5, BioAv↝, 4, Dose↝, 3, eff↑, 1, Half-Life↓, 2, Half-Life↝, 1,
Clinical Biomarkers ⓘ
IL6↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, cardioP↑, 1, hepatoP↓, 1, hepatoP↑, 1, memory↑, 1, neuroP↑, 2, toxicity↓, 1,
Total Targets: 51
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:792 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page